Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.
Clinical trial NCT03898583 · COMPLETED
Trial details
- NCT number
- NCT03898583
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-15
- Primary completion
- 2019-10-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.